FDA approved Pfizer-BioNTech’s XFG-adapted COMIRNATY formula for adults 65 and older and high-risk people aged 5 to 64 years.
News|Videos|July 14, 2020
COVID-19 in the ICU: A Cardiothoracic Surgeon's Experience
Author(s)Grace Halsey
Cardiothoracic surgeon Brian Lima, MD spent weeks in a large metropolitan New York City ICU treating the sickest patients with COVID-19. He shares details.
Advertisement
Brian Lima, MD, director of heart transplant surgery at North Shore University Hospital in New York, turned over his ICU, the hospital's largest, to COVID-19 patients and, like physicians from all over the institution, became a COVID-19 doctor for more than a month. This is what he saw.
Dr Lima is the surgical director of heart transplantation at North Shore University Hospital in Manhasset, New York, and is associate professor of cardiovascular and thoracic surgery at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. @BrianLimaMD
Advertisement
Related to this article
A Vaccine Integrity Project review found influenza, COVID-19, and RSV immunizations continue to protect against severe illness, hospitalization, and death.
Pre-existing antibodies to common microbes predicted COVID-19 vaccine response strength in healthy and immunosuppressed adults.
FDA updates sotatercept-csrk label with HYPERION data, showing earlier use cuts PAH clinical worsening risk 76% alongside background therapy.
A team-based blood pressure intervention delivered through primary care reduced dementia risk by 15% over 7 years.
FDA approved bictegravir/lenacapavir for adults with suppressed HIV-1 and no known or suspected component resistance.
Tirzepatide gained an FDA cardiovascular indication after SURPASS-CVOT showed noninferiority to dulaglutide in high-risk adults.
Physical activity was associated with up to 22% lower mortality and 19% lower stroke risk in adults with and without atrial fibrillation in a large Norwegian cohort study.
Advertisement
Advertisement
Trending on Patient Care Online
1
FDA Approves Insulin Efsitora Alfa-Gobe for Adults With Type 2 Diabetes
2
GLP-1 RAs for Weight Management: A Primary Care Approach to Risk and Monitoring
3
Individualizing Obesity Treatment in Primary Care: An Expert Discussion
4
Safety, Dosing, and Drug Interactions for Dextromethorphan-Bupropion in Agitation
5